Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 0%
Sell 0%
Strong Sell 7%

Bulls say

HealthEquity is a leading provider of healthcare saving and spending solutions and has reported strong financial results for the fourth quarter and fiscal year, with increased cash and decreased long-term debt. With their raised guidance and outstanding HSA business, along with a strong balance sheet, the company is expected to continue its growth and profitability in the expanding HSA market. All these factors combined make HealthEquity a favorable investment opportunity with positive long-term outlook.

Bears say

HealthEquity is facing increasing operating expenses that are eating into its gross profit, with operating expenses growing 6.9% and gross profit only increasing by 20.7%. Although the company's operating income has increased, it may not be sustainable in the long term if the trend continues. Additionally, the company's full-year guidance increase may not be enough to offset these fundamental issues, especially with service revenue only increasing by 2.3%.

HealthEquity (HQY) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 0% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 14 analysts, HealthEquity (HQY) has a Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $115.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $115.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.